1186
S. Mondal et al. / Tetrahedron Letters 52 (2011) 1183–1186
6. (a) Hopf, H.; Musso, H. Angew. Chem. Int., Ed. Engl. 1969, 8, 680; (b) Hopf, H.;
O
H
Kruger, A. Chem. Eur. J. 2001, 7, 4378; (c) Zimmerman, G. Eur. J. Org. Chem. 2001,
457.
O
++
7. (a) Enediyne Antibiotics as Antitumor Agents; Border, D. B., Doyle, T. W., Eds.;
Marcel Dekker: New York, 1995; (b) Cancer Chemo-therapeutic Agents; Foye, W.
O., Ed.; American Chemical Society: Washington, DC, 1995; (c) Bross, P. F.;
Beitz, J.; Chen, G.; Chen, X. H.; Duffy, E.; Kieffer, L.; Roy, S.; Sridhara, R.; Rahman,
A.; Williams, G.; Pazdur, R. Clin. Cancer Res. 2001, 7, 1490.
O
Mn
O
CuSO4;5H2O
Mn
O
O
KMnO4
+
O
O
O
8. (a) Perpall, M. W.; Perera, K. P. U.; DiMaio, J.; Ballato, J.; Foulger, S. H.; Smith, D.
W., Jr. Langmuir 2003, 19, 7153; (b) John, J. A.; Tour, J. M. Tetrahedron 1997, 53,
15515.
9. (a) Grissom, J. W.; Gunawardena, G. U.; Klinberg, D.; Huang, D. Tetrahedron
1996, 52, 6453; (b) Schreiner, P. R.; Prall, M.; Lutz, V. Angew. Chem., Int. Ed.
2003, 42, 5757.
O
O
HMnvO3
O
O
H2O
+
O
OH
10. Stevenson, R.; Weber, J. B. J. Nat. Prod. 1989, 52, 367.
11. Basak, A.; Das, S.; Mallick, D.; Jemmis, E. D. J. Am. Chem. Soc. 2009, 131, 15695.
12. (a) Hui, Y. H.; Chang, C. J.; Mclaughlin, J. L.; Powell, R. G. J. Nat. Prod. 1986, 49,
1175; (b) Chen, C. C.; Hsin, W. C.; Ko, N. F.; Huang, Y. L.; Ou, C. J.; Teng, C. M. J.
Nat. Prod. 1996, 59, 1149; (c) Mohagheghzadeh, A.; Schmidt, T. J.; Alfermann, A.
W. J. Nat. Prod. 2002, 65, 69; (d) Vasile, N.; Elfahmi; Boss, R.; Kayser, O.;
Momekov, G.; Konstantinov, S.; Ionkova, I. J. Nat. Prod. 2006, 69, 1014.
13. (a) Kobayashi, K.; Kanno, Y.; Seko, S.; Suginomi, H. J. Chem. Soc., Perkin Trans. 1
1992, 3111; (b) Padwa, A.; Cochran, J. E. J. Org. Chem. 1995, 60, 3938; (c)
Mizufune, H.; Nakamura, M.; Mitsudera, H. Tetrahedron Lett. 2001, 42, 437; (d)
Harrowven, D. C.; Bradley, M.; Castro, J. L.; Flanagan, S. R. Tetrahedron Lett.
2001, 42, 6973; (e) Capilla, A. S.; Sanchez, I.; Caignard, D. H.; Renard, P.; Pujol,
M. D. Eur. J. Med. Chem. 2001, 42, 437; (f) Sagar, S. K.; Chang, C. C.; Wang, W. K.;
Lin, J. Y.; Lee, S. S. Bioorg. Med. Chem. 2004, 12, 4045; (g) Anastus, P. T.; Foley, P.;
Fghbali, N. J. Nat. Prod. 2010, 73, 811.
O
H
x
MeO
H
R
O
O
H
O
R
Mn
O
O
A
X
O
H
14. The correct IUPAC name of the isofuran derivative is 1,3-dihydro-naphtho[2,3-
c]furan.
H
O
R
15. General procedure: For Garratt–Braverman cyclization: To a solution of bis-
propargyl ether in toluene, KOBut (1.0 equiv) was added and refluxed at 110 °C
for 3 h. It was then evaporated under reduced pressure and diluted with ethyl
acetate, washed with water, brine and dried over Na2SO4. The ethyl acetate
was then evaporated and products were isolated by column chromatography
(Si-gel, petroleum ether–ethyl acetate as eluent).
H
R
O
:
OMe
O
Mn
O
O
For phenols O-methylation: The phenolic compounds were dissolved in acetone
and MeI (2.0 equiv per phenolic OH group) and K2CO3 (1.2 equiv per phenolic
OH group) were added and the mixture was refluxed at 56 °C for 2 h. Acetone
was then evaporated and diluted with water and extracted with ethyl acetate.
The organic layer was washed with brine and dried over Na2SO4. The ethyl
acetate was then evaporated and product was isolated by column
chromatography (Si-gel, petroleum ether–ethyl acetate mixture as eluent).
For benzylic oxidation: Equal weights of potassium permanganate and copper
sulfate pentahydrate were ground together in a mortar. The resulting fine,
B
Y
Scheme 5. Mechanism of lactone formation.
Supplementary data
highly coloured product was used as
a heterogeneous oxidant (3.2 g for
Supplementary data associated with this article can be found, in
1.4 mmol) in a methylene chloride solution of dihydroisofuran derivative and
stirred vigorously under gentle reflux for 72 h. The resulting mixture was then
filtered through a Celite pad and concentrated. The products were isolated by
column chromatography (Si-gel, petroleum ether–ethyl acetate mixture as
eluent).
References and notes
16. A detailed study on the electronic effect on GB cyclization has been carried out
using other electron withdrawing groups like nitro and cyano: Maji, M.;
Mallick, D.; Mondal, S.; Anoop, A.; Bag, S. S.; Basak, A.; Jemmis, E. D.
Org. Lett., accepted for publication. Manuscript under preparation. In the
present work, benzoate was used as the electron withdrawing group as it could
be readily hydrolysed to the phenol.
1. (a) Curran, D. P. Synthesis 1988, 1, 417–439. 2, 489; (b) Jasperse, C. P.; Curran, D.
P.; Feving, T. L. Chem. Rev. 1991, 1237.
2. (a) Jones, R. G.; Bergman, R. G. J. Am. Chem. Soc. 1972, 9, 660; (b) Bergman, R. G.
Acc. Chem. Res. 1973, 6, 25; (c) Lockhart, T. P.; Bergman, R. G. J. Am. Chem. Soc.
1981, 103, 4091.
3. (a) Nagata, R.; Yamanaka, H.; Okazaki, E.; Saito, I. Tetrahedron Lett. 1989, 30,
4995; (b) Myers, A. G.; Kuo, E. Y.; Finney, N. S. J. Am. Chem. Soc. 1989, 111, 8057;
(c) Myers, A. G.; Dragovich, P. S. J. Am. Chem. Soc. 1989, 111, 9130–9132; (d)
Nagata, R.; Yamanaka, H.; Murahashi, E.; Saito, I. Tetrahedron Lett. 1990, 31,
2907.
4. (a) Schmittel, M.; Strittmatter, M.; Kiau, S. Angew. Chem. 1996, 108, 1952; (b)
Schmittel, M.; Kiau, S.; Siebert, T.; Strittmatter, M. Tetrahedron Lett. 1996, 37,
7691; (c) Schmittel, M.; Steffen, J.-P.; Auer, D.; Maywald, M. Tetrahedron Lett.
1997, 38, 6177; (d) Schmittel, M.; Keller, M.; Kiau, S.; Strittmatter, M. Chem. Eur.
J. 1997, 3, 807–816; (e) Schmittel, M.; Strittmatter, M.; Kiau, S. Tetrahedron Lett.
1995, 36, 4975.
17. The selectivity showed by the reaction indicated that the benzoate was
hydrolysed after the GB process.
18. Noureldin, N. A.; Zhao, D.; Lee, D. J. J. Org. Chem. 1997, 62, 8767.
19. Representative spectral data. Compound 15: yellow viscous liquid; Yield 98%; 1
H
NMR (200 MHz, CDCl3) dH 3.17 (3H, s), 3.75 (3H, s), 3.76 (3H, s), 3.86 (3H, s),
4.71 (2H, s), 5.12 (2H, s), 6.82 (2H, d, J = 8.4 Hz), 6.87 (1H, s), 7.08 (2H, d,
J = 8.4 Hz), 7.40 (1H, s). 13C NMR (50 MHz, CDCl3) dC 55.2, 55.7, 60.6, 61.0, 73.4,
73.5, 103.1, 112.9, 117.8, 112.4, 128.9, 130.5, 132.0, 134.2, 136.9, 137.2, 142.2,
150.0, 152.5, 158.1. MS: m/z = 389.14 [MNa+], 367.13 [MH+]; HRMS: calcd for
C
22H22O5+H+ 367.1445; found 367.1461. Compound 15a: yellow viscous liquid;
Yield 89%; 1H NMR (400 MHz, CDCl3) dH 3.30 (3H, s), 3.85 (3H, s), 3.93 (3H, s),
4.02 (3H, s), 5.05 (2H, s), 6.98 (2H, d, J = 8.7 Hz), 7.16 (1H, s), 7.21 (2H, d,
J = 8.7 Hz), 8.30 (1 h, s). MS: m/z = 403.11 [MNa+], 381.12 [MH+]; HRMS: calcd
for C22H20O6+H+ 381.1338; found 381.1347.
5. (a) Braverman, S.; Segev, D. J. Am. Chem. Soc. 1974, 96, 1245; (b) Garratt, P. J.;
Neoh, S. B. J. Org. Chem. 1979, 44, 2667–2674; (c) Cheng, Y. S. P.; Garratt, P. J.;
Neoh, S. B.; Rumjanek, V. H. Isr. J. Chem. 1985, 26, 101; (d) Braverman, S.; Duar,
Y.; Segev, D. Tetrahedron Lett. 1976, 17, 3181; (e) Zafrani, Y.; Gottlieb, H. E.;
Sprecher, M.; Braverman, S. J. Org. Chem. 2005, 70, 10166.